BA
BMY icon

Boston Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Boston Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$2.89M Sell
56,909
-4,945
-8% -$232K 0.15% 185
2019
Q2 		$2.81M Sell
61,854
-10,083
-14% -$470K 0.15% 180
2019
Q1 		$3.43M Buy
71,937
+1,550
+2% +$77.2K 0.18% 161
2018
Q4 		$3.66M Sell
70,387
-2,759
-4% -$148K 0.21% 133
2018
Q3 		$4.54M Sell
73,146
-6,787
-8% -$403K 0.2% 174
2018
Q2 		$4.42M Sell
79,933
-284,346
-78% -$15.4M 0.11% 197
2018
Q1 		$23M Sell
364,279
-11,908
-3% -$766K 0.59% 41
2017
Q4 		$23.1M Sell
376,187
-87,488
-19% -$5.47M 0.5% 48
2017
Q3 		$29.6M Buy
463,675
+36,289
+8% +$2.12M 0.67% 31
2017
Q2 		$23.8M Sell
427,386
-12,055
-3% -$656K 0.55% 35
2017
Q1 		$23.9M Sell
439,441
-49,703
-10% -$2.73M 0.56% 33
2016
Q4 		$28.6M Sell
489,144
-133,473
-21% -$7.3M 0.68% 27
2016
Q3 		$33.6M Buy
622,617
+60,690
+11% +$3.9M 0.83% 22
2016
Q2 		$41.3M Buy
561,927
+400,099
+247% +$28.3M 1.03% 13
2016
Q1 		$10.3M Sell
161,828
-271
-0.2% -$17.1K 0.25% 116
2015
Q4 		$11.2M Buy
162,099
+2,014
+1% +$133K 0.26% 116
2015
Q3 		$9.48M Sell
160,085
-366,835
-70% -$23.3M 0.36% 76
2015
Q2 		$35.1M Buy
526,920
+82,796
+19% +$5.46M 1.46% 6
2015
Q1 		$28.6M Buy
444,124
+11,162
+3% +$699K 1.13% 11
2014
Q4 		$25.6M Sell
432,962
-1,354
-0.3% -$76.4K 1.08% 16
2014
Q3 		$22.2M Buy
434,316
+62,802
+17% +$3.14M 0.94% 25
2014
Q2 		$18M Buy
371,514
+5,396
+1% +$266K 0.77% 29
2014
Q1 		$19M Buy
366,118
+234,815
+179% +$12.5M 0.85% 29
2013
Q4 		$6.98M Sell
131,303
-3,220
-2% -$164K 0.33% 95
2013
Q3 		$6.23M Sell
134,523
-28,207
-17% -$1.24M 0.33% 96
2013
Q2 		$7.27M Buy
+162,730
New +$7.06M 0.35% 89

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Boston Advisors's BMY Position: Q3 2019 in Review

Boston Advisors reduced its Bristol-Myers Squibb (BMY) stake by 8% in Q3 2019, selling an estimated $232K and leaving 56,909 shares worth $2.89M. The position accounts for 0.15% of the portfolio, ranked #185.

Boston Advisors first reported a position in BMY in Q2 2013 and has held it in 26 quarters since. The position peaked at $41.3M in Q2 2016. 1,813 funds tracked by Wall St. Rank hold BMY as of Q3 2019.

  • Boston Advisors held 56,909 shares of Bristol-Myers Squibb worth $2.89M as of Q3 2019.
  • Boston Advisors sold 4,945 Bristol-Myers Squibb shares in Q3 2019, an estimated $232K.
  • Bristol-Myers Squibb made up 0.15% of Boston Advisors's portfolio in Q3 2019, its #185 holding.
  • Boston Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 26 quarters since.
  • Boston Advisors's Bristol-Myers Squibb position peaked at $41.3M in Q2 2016.
  • 1,813 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2019.

Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.